Schweizerischer Nationalfonds / Fonds national suisse
She recognises "super recognisers"
plus
Actualités de Lausanne
FEI Fédération Equestre Internationale
Belgium's Ingmar De Vos re-elected for third and final term as FEI President
Cape Town, South Africa and Lausanne, Switzerland (ots/PRNewswire) - Belgium's Ingmar De Vos has been re-elected with an overwhelming majority by the Fédération Equestre Internationale (FEI) member National Federations to serve a third and final term as FEI President. The Presidential election was held during today's FEI Hybrid General Assembly held in Cape Town ...
plusDebiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial Data
Boston, USA and Lausanne, Switzerland (ots) - - SaaS Platform Provides Missing Link in Clinical Trial Data Collection, Securely Automating Real-Time Transfer of Up-to-Date Patient Data Directly from EHRs to EDC Systems - Technology Brings New Levels of Speed, Quality and Efficiency to Clinical Trial Data Collection ...
plusScreeneo Innovation SA; Philipps
Philips Projection announces the Philips Screeneo U5.
Lausanne, Switzerland (ots/PRNewswire) - The Next Evolution in Ultra Short Throw 4K Laser Projection. Philips Projection is pleased to launch the Philips Screeneo U5, its Ultra Short Throw True 4K UHD Laser Projector that offers a 150" (381cm) breathtaking visual experiences from only 16.5 inches (42cm) away. In continuation to the success of the Screeneo U4 UST projector, the company brings the next evolution to the ...
plusDEBIOPHARM REINFORCES THE BOND BETWEEN SWISS AND JAPANESE CANCER RESEARCH WITH THE 2022 JCA MAUVERNAY AWARD CEREMONY
Lausanne, Switzerland (ots) - Debiopharm awards the winning scientists for the JCA (Japanese Cancer Association) Award for innovative, disruptive, and translational oncology research Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of JCA Mauvernay ...
plusBIG IMPACT, SMALL PACKAGE: DEBIOPHARM LAUNCHES A WAZOKU OPEN-INNOVATION CHALLENGE FOR SMALL ANTIBODY DRUG CONJUGATE TECHNOLOGY
Lausanne, Switzerland (ots) - · Currently approved Antibody-Drug Conjugates (ADCs) are large molecules (150 kDa) composed of an antibody, a cytotoxic payload, and a linker connecting the two precedent elements · Debiopharm has launched an ADC Innovation Challenge to a pool of international “problem Solvers” ...
plus
Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence
Lausanne, Switzerland (ots/PRNewswire) - Debiopharm Innovation Fund strategically invests in Whitelab Genomics' mission to make genomic medicine development faster and leaner for more efficient access to cancer patients in the future Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical ...
plusDebiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence
Lausanne (ots) - Debiopharm Innovation Fund strategically invests in Whitelab Genomics' mission to make genomic medicine development faster and leaner for more efficient access to cancer patients in the future Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm ...
plusONE DRUG FOR ONE BUG: DEBIOPHARM TO DISCUSS THE POTENTIAL OF PATHOGEN-SPECIFIC ANTIBIOTICS AT THE 2022 WORLD AMR CONGRESS
Lausanne, Switzerland (ots) - - International health authorities, such as the WHO and the CDC are warning of the emerging danger of bacterial infections resistant to current antibiotics - The 2022 World Anti-Microbial Resistance (AMR) Congress in the greater Washington D.C. area is serving as a forum to openly ...
plusSchweizerischer Nationalfonds / Fonds national suisse
Broad-based Swiss Covid-19 research
Bern (ots) - During the coronavirus pandemic, the Swiss National Science Foundation (SNSF) supported a total of 114 Covid-19 research projects, for which it used funding of over CHF 45 million. In the National Research Programme "Covid-19" (NRP 78), around 200 researchers are working in 28 projects with a total budget of CHF 20 million. Another research programme on Covid-19 is about to start. It was the first time the ...
plusFirmenich Wins Prestigious Diversity & Inclusion Award
Geneva (ots/PRNewswire) - Recognized as D&I leader by the Cercle Suisse des Administratrices Firmenich, the world's largest privately-owned fragrance and taste company, has announced it has been recognized for its exemplary leadership in Diversity & Inclusion, winning the Cercle Suisse des Administratrices Grandes Entreprises Award 2022. The Cercle Suisse des Administratrices is an association that promotes diversity and ...
plusFirmenich appoints Dr Eric Frérot as Distinguished Scientist
Geneva (ots/PRNewswire) - Firmenich, the world's largest privately-owned fragrance and taste company, is proud to announce the appointment of Dr Eric Frérot as Distinguished Scientist. This nomination acknowledges his successful track-record within R&D, his instrumental role in breakthrough innovations, and his consistent exceptional performance in the field of science. He is one of only seven scientists inside the ...
plus
Schweizerischer Nationalfonds / Fonds national suisse
Should we rely on other tree species to adapt to global warming?
Bern (ots) - Pubescent oak trees thrive even at higher temperatures, in part because they are active earlier in the year. Researchers supported by the SNSF put the trees of the future to the test. As trees grow, they absorb ever greater amounts of CO2 from the atmosphere. Consequently, the health of trees both determines climate and is determined by it. During ...
plusAkman Finance ensures succession via sale to Credaris
plusCompass Financial Technologies
COMPASS FINANCIAL TECHNOLOGIES AND MAREX TO COLLABORATE ON DIGITAL ASSET INVESTMENT SOLUTIONS
Lausanne, Switzerland and London (ots/PRNewswire) - Compass Financial Technologies, a Swiss and French based EU regulated index provider and Marex Solutions, Marex's hedging and investment solutions arm that specialises in customised derivative products, collaborate to offer digital asset investment solutions for institutional investors. Marex will leverage the ...
plusCredaris and Milenia join forces
plusSeries A financing round lays foundation for international growth of digital cancer therapeutics Mika
Berlin/Lausanne/Barcelona/Munich (ots) - New investors with a successful track record in digital oncology support German Digital Therapeutics (DTx) company Fosanis to broaden patient access of Mika - an app-based DTx platform empowering people affected by cancer. Berlin-based digital health company Fosanis, the ...
plusSchweizerischer Nationalfonds / Fonds national suisse
882 million francs invested in research in 2021
Bern (ots) - Last year, the SNSF selected around 1800 research projects for funding. It also launched new funding measures because Swiss researchers are not able to participate in important areas of the Horizon Europe programme. Expanding knowledge and solving problems. That is what thousands of SNSF-funded research teams do at Swiss universities and other higher education institutions. Their curiosity and their ...
plus
DEBIOPHARM ANNOUNCES ONCOLOGY RESEARCH ADVANCEMENTS AT AACR 2022 FOR NOVEL CANCER COMPOUNDS AND DRUG DELIVERY TECHNOLOGIES
plusCompass Financial Technologies
COMPASS LAUNCHES FUNDAMENTAL DEFI INDEX AS INSTITUTIONAL DEMAND IN DIGITAL ASSETS CONTINUES TO SOAR
Lausanne, Switzerland (ots/PRNewswire) - Compass Financial Technologies, a leading crypto index provider that calculates indices that track over $5bn in assets announces the launch of the Compass Crypto Basket Fundamental DeFi Index (CCBFDEFI) - providing a reliable institutional benchmark to one of the fastest growing sectors in the crypto industry. The CCBFDEFI is ...
plusDEBIOPHARM AND ASPEN PARTNER TO LAUNCH PROSTATE CANCER DRUG TRELSTAR® IN SOUTH AFRICA
Lausanne, Switzerland and Durban, South Africa (ots) - Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company and Aspen, a South African headquartered multinational pharmaceutical company announced today their partnership to launch Trelstar® (Triptorelin) in South Africa for the treatment of locally advanced and metastatic hormone dependent prostate ...
plusSeasoned Partner from Boston Consulting Group joins AWK
plusAWK Group appoints Peter Geissbühler as Partner
plusDEBIOPHARM IINVESTS IN VERISIM LIFE’S $15M SERIES A ROUND TO ADVANCE AI-ENABLED DRUG RESEARCH
Lausanne, Switzerland - San Francisco (ots) - Funding to support BIOiSIMTM computational platform to reduce the need for animal testing by selecting compounds showing promise to cure a disease prior to research in humans Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today their co-investment in California-based start-up VeriSIM Life’s ...
plus
Schmuel Holles now partner at AWK Group
plusDEBIOPHARM FURTHER EXPLORES THE POTENTIAL OF ITS POTENT, HIGHLY SELECTIVE WEE1 INHIBITOR DEBIO 0123 IN PHASE 1 CANCER STUDY
Lausanne, Switzerland (ots) - Dose escalation, monotherapy trial launched to access the safety and preliminary anti-tumor activity of Debio 0123 in the treatment of advanced solid tumors Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today the first patient treated in the newly ...
pluselea Foundation for Ethics in Globalization
Peter Maurer is set to join elea Foundation's Comité de Patronage
plusArtificial Intelligence Formulae Generator Recognized for Augmenting the Group's Flavor & Fragrance Creation
Geneva (ots/PRNewswire) - Firmenich, the world's largest privately-owned fragrance and taste company, has won Digital Innovation Of The Year at the Digital Economy Award 2021 in Switzerland. This recognition celebrates the Group's ground-breaking Artificial Intelligence (AI) capabilities and its new Formulae ...
plusSwiss-based Debiopharm co-invests in the future of cell therapies on a chip through the latest $25 million Series A round for Mekonos
Lausanne, Switzerland - San Francisco (ots) - Funding to accelerate the development of Mekonos’ System on a Chip (SoC), expand commercial partnerships Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today having invested $4M inMekonos, a biotech company building the future of cell ...
plusPoda Lifestyle and Wellness Ltd.
Former Big Tobacco Sales Leader Joins Poda
Vancouver, Bc (ots/PRNewswire) - PODA HOLDINGS, INC. ("Poda" or the "Company") (CSE: PODA) (FSE: 99L) (OTC: PODAF)is pleased to announce that former big tobacco sales leader, Christoph Tepr ("Tepr"), has joined Poda. Tepr has accepted an upcoming employment position with the Company as Vice President of European Sales & International Expansion, which is expected to commence on January 17th, 2022. In the interim, Tepr has ...
plus
Précédent1234567Suivant